Ekso Bionics Plans AI-Focused Merger With Applied Digital

EKSO BIONICS ( (EKSO) ) just unveiled an announcement.

On December 29, 2025, Ekso Bionics and Applied Digital Corporation signed an exclusive, non-binding term sheet for a proposed business combination between Applied Digital’s cloud computing arm, Applied Digital Cloud, and Ekso, to form ChronoScale Corporation, a dedicated accelerated compute platform aimed at high-performance GPU infrastructure for artificial intelligence workloads. Under the contemplated terms, Applied would own about 97% of the combined entity, with Ekso shareholders holding roughly 3%, while Ekso continues to explore strategic options for selling all or substantially all of its existing exoskeleton business; the deal, which targets closing in the first half of 2026, would separate Applied’s cloud platform from its data center development operations and, if completed, would reposition Ekso’s listed vehicle into the AI infrastructure space, subject to due diligence, definitive agreements, regulatory and shareholder approvals, and other customary closing conditions.

The most recent analyst rating on (EKSO) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on EKSO BIONICS stock, see the EKSO Stock Forecast page.

Spark’s Take on EKSO Stock

According to Spark, TipRanks’ AI Analyst, EKSO is a Neutral.

EKSO BIONICS’ overall stock score is primarily impacted by its challenging financial performance and weak technical indicators. The company’s ongoing losses and reliance on external financing are significant concerns. Additionally, the negative P/E ratio and lack of dividend yield further weigh down the valuation score. The absence of positive earnings call insights or corporate events leaves these areas neutral.

To see Spark’s full report on EKSO stock, click here.

More about EKSO BIONICS

Ekso Bionics Holdings, Inc., listed on Nasdaq as EKSO, is a leading developer of robotic exoskeleton solutions designed to enhance strength, endurance and mobility in medical and industrial settings, with products that range from enabling people with paralysis to stand and walk to augmenting workers’ physical capabilities on job sites worldwide. The company focuses on improving health and quality of life through advanced robotics that enhance, amplify and restore human function, positioning it as a specialized player at the intersection of medical technology and industrial wearables.

Average Trading Volume: 135,321

Technical Sentiment Signal: Sell

Current Market Cap: $18.86M

For a thorough assessment of EKSO stock, go to TipRanks’ Stock Analysis page.